Morgens Waterfall Vintiadis & CO Inc United Therapeutics Corp Transaction History

Morgens Waterfall Vintiadis & CO Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$212.99 - $276.17 $489,877 - $635,191	2,300 Added 35.94%	8,700 $1.95 Million
Q4 2022 Feb 14, 2023	SELL	$205.95 - $280.43 $823,800 - $1.12 Million	-4,000 Reduced 38.46%	6,400 $1.78 Million
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $1.46 Million - $1.76 Million	7,200 Added 225.0%	10,400 $2.18 Million
Q2 2022 Aug 15, 2022	BUY	$174.81 - $241.14 $559,392 - $771,648	3,200 New	3,200 $754,000

669

42.8M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.7B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Morgens Waterfall Vintiadis & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Morgens Waterfall Vintiadis & CO Inc with notifications on news.